This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCracken, M. A. Articles by Strobl, J. S. Search for Related Content PubMed PubMed Citation Articles by McCracken, M. A. Articles by Strobl, J. S.

Department of Biochemistry and Molecular Pharmacology, and Genetics and Developmental Biology Program, West Virginia University, Morgantown, West Virginia 26506 [M. A. M., J. S. S.], and Isis Pharmaceuticals, Carlsbad Research Center, Carlsbad, California 92008 [L. J. M., R. A. M.]

² To whom requests for reprints should be addressed, at Department of Biochemistry and Molecular Pharmacology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506. Phone: (304) 293-7151; Fax: (304) 293-6854; E-mail: jstrobl{at}hsc.wvu.edu

Protein kinase C (PKC) promotes cell survival in response to ionizing radiation in a variety of experimental models including human carcinoma, human glioblastoma, and transformed mouse embryo fibroblast cell lines. We have introduced specific antisense oligonucleotides into human mammary tumor cell lines in vitro to analyze the role of individual PKC isoforms in radiation-induced cell death in breast cancer. MDA-MB-231 and MCF-7 cells treated with oligonucleotide directed against the PKC isoform exhibited impaired survival in response to 5.6 Gy -radiation as measured by mitochondrial metabolism of tetrazolium dye. The role of PKC in the breast tumor cell lines was of particular interest, because contradictory reports exist in the literature regarding the role of PKC in cell survival and apoptosis. A comparison of the effects of the PKC antisense oligonucleotide and a nucleotide scrambled version of this nucleotide revealed only the antisense oligonucleotide decreased cell survival. The PKC antisense oligonucleotide decreased cell survival after exposure to low (1.5 Gy) radiation doses and in the absence of radiation insult. We found 3 µM rottlerin, a selective PKC inhibitor, to reduce MCF-7 and MDA-MB-231 cell survival. Furthermore, MCF-7 cells transformed to express a dominant-negative mutant of PKC exhibited reduced survival. Comet analysis showed that PKC oligonucleotide treatment caused an accumulation of cells containing damaged DNA similar to that seen in 1.5 Gy radiation-treated cells. We conclude that PKC acts as a prosurvival factor in human breast tumor cells in vitro.

This article has been cited by other articles:

				S. Xia, L. W. Forman, and D. V. Faller Protein Kinase C{delta} Is Required for Survival of Cells Expressing Activated p21RAS J. Biol. Chem., May 4, 2007; 282(18): 13199 - 13210. [Abstract] [Full Text] [PDF]

				D. Alonso-Escolano, C. Medina, K. Cieslik, A. Radomski, P. Jurasz, M. J. Santos-Martinez, T. Jiffar, P. Ruvolo, and M. W. Radomski Protein Kinase C{delta} Mediates Platelet-Induced Breast Cancer Cell Invasion J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 373 - 380. [Abstract] [Full Text] [PDF]

				C. H. Nguyen and V. J. Watts Dexamethasone-Induced Ras Protein 1 Negatively Regulates Protein Kinase C {delta}: Implications for Adenylyl Cyclase 2 Signaling Mol. Pharmacol., May 1, 2006; 69(5): 1763 - 1771. [Abstract] [Full Text] [PDF]

				Q. Pan, L. W. Bao, C. G. Kleer, M. S. Sabel, K. A. Griffith, T. N. Teknos, and S. D. Merajver Protein Kinase C{varepsilon} Is a Predictive Biomarker of Aggressive Breast Cancer and a Validated Target for RNA Interference Anticancer Therapy Cancer Res., September 15, 2005; 65(18): 8366 - 8371. [Abstract] [Full Text] [PDF]

				J. B. Barry and V. Giguere Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells Results in Selective Target Gene Activation by Orphan Nuclear Receptor Estrogen-Related Receptor {alpha} Cancer Res., July 15, 2005; 65(14): 6120 - 6129. [Abstract] [Full Text] [PDF]

				D. N. JACKSON and D. A. FOSTER The enigmatic protein kinase C{delta}: complex roles in cell proliferation and survival FASEB J, April 1, 2004; 18(6): 627 - 636. [Abstract] [Full Text] [PDF]

				Q. Wang, X. Wang, and B. M. Evers Induction of cIAP-2 in Human Colon Cancer Cells through PKC{delta}/NF-{kappa}B J. Biol. Chem., December 19, 2003; 278(51): 51091 - 51099. [Abstract] [Full Text] [PDF]